1H NMR assignment corrections and 1H, 13C, 15N NMR coordination shifts structural correlations in Fe(II), Ru(II) and Os(II) cationic complexes with 2,2′‐bipyridine and 1,10‐phenanthroline

¹H, ¹³C and ¹⁵N NMR studies of iron(II), ruthenium(II) and osmium(II) tris‐chelated cationic complexes with 2,2′‐bipyridine and 1,10‐phenanthroline of the general formula [M(LL)₃]²⁺ (M = Fe, Ru, Os; LL = bpy, phen) were performed. Inconsistent literature ¹H signal assignments were corrected. Significant shielding of nitrogen‐adjacent protons [H(6) in bpy, H(2) in phen] and metal‐bonded nitrogens was observed, being enhanced in the series Ru(II) → Os(II) → Fe(II) for ¹H, Fe(II) → Ru(II) → Os(II) for ¹⁵N and bpy → phen for both nuclei. The carbons are deshielded, the effect increasing in the order Ru(II) → Os(II) → Fe(II). Copyright © 2010 John Wiley & Sons, Ltd.     

Preparation of stannyl complexes of ruthenium and osmium stabilised by polypyridine and phosphite ligands

Trichlorostannyl complexes [M(SnCl3)(bpy)2P]BPh4 [M = Ru, P = P(OEt)(3), 1a PPh(OEt)2 1b; M = Os, P = P(OEt)3 2; bpy = 2,2'-bipyridine] were prepared by allowing chloro complexes [MCl(bpy)2P]BPh4 to react with SnCl2 in 1,2-dichloroethane. Bis(trichlorostannyl) compounds Ru(SnCl3)2(N-N)P2 [N-N = bpy, P = P(OEt)3 3a, PPh(OEt)2 3b; N-N = 1,10-phenanthroline (phen), P = P(OEt)3 4] were also prepared by reacting [RuCl(N-N)P3]BPh4 precursors with SnCl2.2H2O in ethanol. Treatment of both mono- 1a, 2 and bis 3a trichlorostannyl complexes with NaBH4 afforded mono- and bis(trihydridestannyl) derivatives [M(SnH3)(bpy)2P]BPh4 5, 6 and Ru(SnH3)2(bpy)P2 7[P = P(OEt)3], respectively. Treatment of 1a, 2 with MgBrMe gave the trimethylstannyl complexes [M(SnMe3)(bpy)2P]BPh4 8, 9 and treatment of 3a afforded the bis(stannyl) Ru(SnClMe2)2(bpy)P2 10 derivative. Alkynylstannyl complexes [M{Sn(C triple bond CR)3}(bpy)2P]BPh4 11-13 and Ru[Sn(C triple bond CR)3]2(N-N)P2 14-17(R = p-tolyl, Bu t; N-N = bpy, phen) were also prepared by allowing trichlorostannyl compounds 1-4 to react with Li+[RC triple bond C]* in thf. The complexes were characterised spectroscopically and by the X-ray crystal structure determination of [Ru(SnMe3)(bpy)2{P(OEt)3}]BPh4 derivative.     

草酸根桥联的Cu_2~ⅡFe~Ⅲ、Ni_2~ⅡFe~Ⅲ、Co_2~ⅡFe~Ⅲ异三核配合物的合成、表征及抗菌活性

合成了 7种草酸根桥联的 Cu 2 Fe 、Ni 2 Fe 、Co 2 Fe 异三核配合物 [M2 Fe(C2 O4) 3Lx](Cl O4) ,(M=Cu,L=bpy,Me2 phen,NO2 phen,x=2 ;M=Ni,Co,L=bpy,Me2 phen,x=4 ) .经元素分析、摩尔电导和磁性的测定以及红外光谱和电子光谱等方法对这些配合物进行了表征 ,确定了配合物的组成和结构 .初步生物活性试验表明形成异三核配合物后其杀菌活性明显提高     

Synthesis of heteroleptic bis(diimine)carbonylchlororuthenium(II) complexes from photodecarbonylated precursors

The reactions of bidentate diimine ligands (L2) with binuclear [Ru(L1)(CO)Cl2]2 complexes [L1 not equal to L2 = 2,2'-bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (4,4'-Me2bpy), 5,5'-dimethyl-2,2'-bipyridine (5,5'-Me2bpy), 1,10-phenanthroline (phen), 4,7-dimethyl-1,10-phenanthroline (4,7-Me2phen), 5,6-dimethyl-1,10-phenanthroline (5,6-Me2phen), di(2-pyridyl)ketone (dpk), di(2-pyridyl)amine (dpa)] result in cleavage of the dichloride bridge and the formation of cationic [Ru(L1)(L2)(CO)Cl]+ complexes. In addition to spectroscopic characterization, the structures of the [Ru(bpy)(phen)(CO)Cl]+, [Ru(4,4'-Me2bpy)(5,6-Me2phen)(CO)Cl]+ (as two polymorphs), [Ru(4,4'-Me2bpy)(4,7-Me2phen)(CO)Cl]+, [Ru(bpy)(dpa)(CO)Cl]+, [Ru(5,5'-Me2bpy)(dpa)(CO)Cl]+, [Ru(bpy)(dpk)(CO)Cl]+, and [Ru(4,4'-Me2bpy)(dpk)(CO)Cl]+ cations were confirmed by single crystal X-ray diffraction studies. In each case, the structurally characterized complex had the carbonyl ligand trans to a nitrogen from the incoming diimine ligand, these complexes corresponding to the main isomers isolated from the reaction mixtures. The synthesis of [Ru(4,4'-Me2bpy)(5,6-Me2bpy)(CO)(NO3)]+ from [Ru(4,4'-Me2bpy)(5,6-Me2bpy)(CO)Cl]+ and AgNO3 demonstrates that exchange of the chloro ligand can be achieved.     

The synthesis and structure of heteroleptic tris(diimine)ruthenium(II) complexes

The reactions of bidentate diimine ligands (L2) with cationic bis(diimine)[Ru(L)(L1)(CO)Cl]+ complexes (L, L1, L2 are dissimilar diimine ligands), in the presence of trimethylamine-N-oxide (Me3NO) as a decarbonylation reagent, lead to the formation of heteroleptic tris(diimine) ruthenium(II) complexes, [Ru(L)(L1)(L2)]2+. Typically isolated as hexafluorophosphate or perchlorate salts, these complexes were characterised by UV-visible, infrared and mass spectroscopy, cyclic voltammetry, microanalyses and NMR spectroscopy. Single crystal X-ray studies have elucidated the structures of K[Ru(bpy)(phen)(4,4'-Me(2)bpy)](PF(6))(3).1/2H(2)O, [Ru(bpy)(5,6-Me(2)phen)(Hdpa)](ClO(4))(2), [Ru(bpy)(phen)(5,6-Me(2)phen)](ClO(4))(2), [Ru(bpy)(5,6'-Me(2)phen)(4,4'-Me(2)bpy)](PF(6))(2).EtOH, [Ru(4,4'-Me(2)bpy)(phen)(Hdpa)](PF(6))(2).MeOH and [Ru(bpy)(4,4'-Me(2)bpy)(Hdpa)](ClO(4))(2).1/2Hdpa (where Hdpa is di(2-pyridyl)amine). A novel feature of the first complex is the presence of a dinuclear anionic adduct, [K(2)(PF(6))(6)](4-), in which the two potassium centres are bridged by two fluorides from different hexafluorophosphate ions forming a K(2)F(2) bridging unit and by two KFPFK bridging moieties.     

Formation and reactivity of the Os(IV)-azidoimido complex, PPN[Os(IV)(bpy)(Cl)(3)(N(4))

Reactions between the Os(VI)-nitrido complexes, [OsVI(L2)(Cl)3(N)] (L2 = 2,2'-bipyridine (bpy) ([1]), 4,4'-dimethyl-2,2'-bipyridine (Me2bpy), 1,10-phenanthroline (phen), and 4,7-diphenyl-1,10-phenanthroline (Ph2phen)), and bis-(triphenylphosphoranylidene)ammonium azide (PPNN3) in dry CH3CN at 60 degrees C under N2 give the corresponding Os(IV)-azidoimido complexes, [OsIV(L2)(Cl)3(NN3)]- (L2 = bpy = [2]-, L2 = Me2bpy = [3]-, L2 = phen = [4]-, and L2 = Ph2phen = [5]-) as their PPN+ salts. The formulation of the N42- ligand has been substantiated by 15N-labeling, IR, and 15N NMR measurements. Hydroxylation of [2]- at Nalpha with O<--NMe3.3H2O occurs to give the Os(IV)-azidohydroxoamido complex, [OsIV(bpy)(Cl)3(N(OH)N3)] ([6]), which, when deprotonated, undergoes dinitrogen elimination to give the Os(II)-dinitrogen oxide complex, [OsII(bpy)(Cl)3(N2O)]- ([7]-). They are the first well-characterized examples of each kind of complex for Os.     

Di- and tetranuclear ruthenium(II) and/or osmium(II) complexes of polypyridyl ligands bridged by a fully conjugated aromatic spacer: synthesis,characterization, and electrochemical and photophysical studies

A series of mono-, di-, and tetranuclear homo/heterometallic complexes of Ru(II) and Os(II) based on the bridging ligand dppz(11-11')dppz (where dppz = dipyrido[3,2-a:2',3'-c]phenazine) (BL) have been synthesized and characterized. This bridging ligand is a long rigid rod with only one rotational degree of freedom and provides complete conjugation between the chromophores. The complexes synthesized are of general formula [(bpy)(2)Ru-BL](2+), [(phen)(2)/(bpy)(2)M-BL-M(bpy)(2)/(phen)(2)](4+) (M = Ru(II) and Os(II)), [(bpy)(2)Ru-BL-Os(bpy)(2)](4+), and [((bpy)(2)Ru-BL)(3)M](8+). Detailed (1)H NMR studies of these complexes revealed that each chiral center does not influence its neighbor because of the long distance between the metal centers and the superimposed resonances of the diastereoisomers, which allowed the unambiguous assignment of the signals, particularly for homonuclear complexes. Concentration-dependent (1)H NMR studies show molecular aggregation of the mono- and dinuclear complexes in solution by pi-pi stacking. Electrospray mass spectrometry data are consistent with dimerization of mono- and dinuclear complexes in solution. Electrochemical studies show oxidations of Ru(II) and Os(II) in the potential ranges +1.38 to +1.40 and +0.92 to +1.01 V, respectively. The bridging ligand exhibits two one-electron reductions, and it appears that the added electrons are localized on the phenazene moieties of the spacer. All of these complexes show strong metal-to-ligand charge-transfer (MLCT) absorption and (3)MLCT luminescence at room temperature. Quantum yields have been calculated, and the emission lifetimes of all complexes have been measured by laser flash photolysis experiments. The luminescence intensity and lifetime data suggest that the emission due to the Ru center of the heteronuclear complexes is strongly quenched (>90%) compared to that of the corresponding model complexes. This quenching is attributed to intramolecular energy transfer from the Ru(II) center to the Os(II) center (k = (3-5) x 10(7) s(-1)) across the bridging ligand.     

Synthesis and cytotoxicity of dinuclear complexes containing ruthenium(II) bipyridyl units linked by a bis(pyridylimine) ligand

Enantiopure dinuclear ruthenium polypyridyl complexes of the form [Ru(2)(LL)(4)L(1)](PF(6))(4) (LL = 2,2'-bipyridine (bpy) or 1,10-phenanthroline (phen); L(1)= C(25)H(20)N(4) a bis(pyridylimine) ligand containing a diphenylmethane spacer) have been synthesized using the chiral building blocks cis-[Ru(bpy)(2)(py)(2)](2+) and cis-[Ru(phen)(2)(py)(2)](2+). These dinuclear ruthenium complexes have been characterised using NMR, mass spectrometry, UV-visible absorbance, circular dichroism and linear dichroism. The compounds exhibit good photo and thermal stability. The extinction coefficient for the bpy complex at 478 nm is epsilon(478) = 15,700 mol(-1) cm(-1) dm(3) and for the phen complex is epsilon(478) = 24,900 mol(-1) cm(-1) dm(3). Both complexes have their longest wavelength (metal to ligand charge transfer) transition predominantly x/y (short axis)-polarised while the transitions at shorter wavelength are a mixture of x/y and z-polarisations, similar to both the copper helicate and iron triple helicate studied previously. Cytotoxicity studies reveal that the compounds are dramatically less active against cancer cell lines than the recently reported supramolecular cylinders prepared from the same bis(pyridylimine) ligand.     

N,N'-乙二水杨酰胺合铜(II)酸根和N,N'-1,2-丙二水杨酰胺全铜(II)酸根的双核Cu(II)-Fe(III)配合物的合成和磁性

本文合成了四个新型双核配合物、[Cu(samen)Fe(L)Cl]和[Cu(sampn)Fe(L)Cl]。经元素分析、IR, 电导、磁性测量等手段推定配合物具有酚氧桥结构, Cu(II)及Fe(III)的配位环境分别为平面四方及四角锥的构型, Fe(III)离子的自旋态S=3/2。测定了配合物[Cu(samen)Fe(L)Cl]的变温磁化率(4-300K), 参数J和θ值表明两个双核配合物中金属离子之间有中等程度的反铁磁性超交换作用和双核单元之间有弱的分子间相互作用。     

Electron tunneling in single crystals of Pseudomonas aeruginosa azurins.

Rates of reduction of Os(III), Ru(III), and Re(I) by Cu(I) in His83-modified Pseudomonas aeruginosa azurins (M-Cu distance approximately 17 A) have been measured in single crystals, where protein conformation and surface solvation are precisely defined by high-resolution X-ray structure determinations: 1.7(8) x 10(6) s(-1) (298 K), 1.8(8) x 10(6) s(-1) (140 K), [Ru(bpy)2(im)(3+)-]; 3.0(15) x 10(6) s(-1) (298 K), [Ru(tpy)(bpy)(3+)-]; 3.0(15) x 10(6) s(-1) (298 K), [Ru(tpy)(phen)(3+)-]; 9.0(50) x 10(2) s(-1) (298 K), [Os(bpy)2(im)(3+)-]; 4.4(20) x 10(6) s(-1) (298 K), [Re(CO)3(phen)(+)] (bpy = 2,2'-bipyridine; im = imidazole; tpy = 2,2':6',2' '-terpyridine; phen = 1,10-phenanthroline). The time constants for electron tunneling in crystals are roughly the same as those measured in solution, indicating very similar protein structures in the two states. High-resolution structures of the oxidized (1.5 A) and reduced (1.4 A) states of Ru(II)(tpy)(phen)(His83)Az establish that very small changes in copper coordination accompany reduction but reveal a shorter axial interaction between copper and the Gly45 peptide carbonyl oxygen [2.6 A for Cu(II)] than had been recognized previously. Although Ru(bpy)2(im)(His83)Az is less solvated in the crystal, the reorganization energy for Cu(I) --> Ru(III) electron transfer falls in the range (0.6-0.8 eV) determined experimentally for the reaction in solution. Our work suggests that outer-sphere protein reorganization is the dominant activation component required for electron tunneling.     

Mononuclear and dinuclear complexes of dibenzoeilatin: synthesis, structure, and electrochemical and photophysical properties

This work describes a study of Ru(II) and Os(II) polypyridyl complexes of the symmetrical, fused-aromatic bridging ligand dibenzoeilatin (1). The synthesis, purification, and structural characterization by NMR of the mononuclear complexes [Ru(bpy)(2)(dbneil)](2+) (2), [Ru(tmbpy)(2)(dbneil)](2+) (3), and [Os(bpy)(2)(dbneil)](2+) (4), the homodinuclear complexes [[Ru(bpy)(2)](2)[micro-dbneil]](4+) (5), [[Ru(tmbpy)(2)](2)[micro-dbneil]](4+) (6), and [[Os(bpy)(2)](2)[micro-dbneil]](4+) (7), and the heterodinuclear complex [[Ru(bpy)(2)][micro-dbneil][Os(bpy)(2)]](4+) (8) are described, along with the crystal structures of 4, 6, and 7. Absorption spectra of the mononuclear complexes feature a low-lying MLCT band around 600 nm. The coordination of a second metal fragment results in a dramatic red shift of the MLCT band to beyond 700 nm. Cyclic and square wave voltammograms of the mononuclear complexes exhibit one reversible metal-based oxidation, as well as several ligand-based reduction waves. The first two reductions, attributed to reduction of the dibenzoeilatin ligand, are substantially anodically shifted compared to [M(bpy)(3)](2+) (M = Ru, Os), consistent with the low-lying pi orbital of dibenzoeilatin. The dinuclear complexes exhibit two reversible, well-resolved, metal-centered oxidation waves, despite the chemical equivalence of the two metal centers, indicating a significant metal-metal interaction mediated by the conjugated dibenzoeilatin ligand. Luminescence spectra, quantum yield, and lifetime measurements at room temperature in argon-purged acetonitrile have shown that the complexes exhibit (3)MLCT emission, which occurs in the IR-region between 950 and 1300 nm. The heterodinuclear complex 8 exhibits luminescence only from the Ru-based fragment, the intensity of which is less than 1% of that observed in the corresponding homodinuclear complex 5; no emission from the Os-based unit is observed, and an intramolecular quenching constant of k(q) > or = 3 x10(9) s(-)(1) is evaluated. The nature of the quenching process is briefly discussed.     

Synthesis, characterization, solid-state structures, and spectroscopic properties of two catechol-based luminescent chemosensors for biologically relevant oxometalates

The new heteroditopic ligand 2,3-dihydroxy-N-(1,10-phenanthroline-5-yl)benzamide (H2-L3) was synthesized and coordinated to [Ru(bpy)2(phen)]2+- and [ReBr(CO)3(phen)]-type luminophores (bpy = 2,2'-bipyridine and phen = 1,10-phenanthroline). The resulting chemosensors [Ru(bpy)2(H2-L3)]2+ and [ReBr(CO)3(H2-L3)] were fully characterized and their solid-state structures and spectroscopic properties were investigated to assess how the photophysical properties of the luminescent signaling units affect the performance of the sensors. [Ru(bpy)2(H2-L3)]2+ and [ReBr(CO)3(H2-L3)] both signal the presence and concentration of molybdate and vanadate in aqueous acetonitrile through a decrease in emission intensity. [ReBr(CO)3(H2-L3)] also detects tungstate. Due to the higher emission intensity of the Ru-based sensor, its detection limits for molybdate (43 microg L(-1)) and vanadate (24 microg L(-1)) are almost 1 order of magnitude lower than the ones achieved with the Re-based sensor. The optimum working pH of the chemosensors is determined by the pKa values of the 2-hydroxy-groups of the receptor units: pH 4 for [ReBr(CO)3(H2-L3)] and pH 3 for [Ru(bpy)2(H2-L3)]2+. Both sensors are selective: equimolar amounts of PO4(3-), SO4(2-), ReO4-, Mn(II), Fe(III), Co(II), Ni(II), Cu(II), and Zn(II) do not interfere with the detection of molybdate or vanadate.     

四吡啶[3，2-a：2＇，3＇-c：3＂，2＂-h：2＂＇，3＂＇-j]吩嗪的钴、镍双核配合物的合成、表征及光谱学性质研究

为了提高产率,以5,6-二胺-1,10-邻菲咯啉与1,10-邻菲咯啉-5,6-二酮反应,合成了配体四吡啶[3,2-a：2＇,3＇-c：3＂,2"-h：2＂＇,3＂＇-j]吩嗪(tpphz)。以此配体为桥合成了钴㈣、镍(Ⅱ)为中心金属的三种新的双核配合物。用元素分析、红外光谱、质子核磁共振、热重分析、中心金属滴定等手段对配合物进行了结构表征,并研究了其紫外和荧光光谱性质。     

Sequence information, distinction and quantitation of C-terminal leucine and isoleucine in ternary complexes of tripeptides with Cu(II) and 2,2'-bipyridine

Tripeptides form ternary complexes with Cu(2+) and 2,2'-bipyridine (bpy) that self-assemble upon mixing the components in aqueous methanol solution. Electrospray ionization (ESI) of the complex solutions provides abundant singly charged [Cu(peptide -- H)bpy](+) and doubly charged [Cu(peptide)bpy](2+) ions. Collision-induced dissociation (CID) at low ion kinetic energies of several tripeptides, AGG, GGA, LGG, GGL, GGI, FGG, GGF, LGF, GLF, GFL, GYA and GAY, showed fragments that were indicative of the amino acid sequence in the peptide. In addition, CID of single and doubly charged complexes of isomeric tripeptides GGL and GGI provided unambiguous distinction of the isomeric leucine and isoleucine residues. Leucine peptides eliminated C(3)H(7) radicals from the amino acid side-chain whereas isoleucine eliminated C(2)H(5) radicals. CID of gas-phase doubly charged peptide complexes in a quadrupole ion trap produced a series of singly charged sequence fragments that following isolation and further CID furnished distinct fragments that allowed quantitation of leucine and isoleucine-containing peptides in mixtures.     

草酸根桥联的CuⅡ2FeⅢ、NiⅡ2FeⅢ、CoⅡ2FeⅢ异三核配合物的合成、表征及抗菌活性

合成了7种草酸根桥联的CuⅡ2FeⅢ、NiⅡ2FeⅢ、CoⅡ2FeⅢ异三核配合物[M2Fe(C2O4)3Lx](ClO4),(M=Cu,L=bpy,Me2phen,NO2phen,x=2;M=Ni,Co,L=bpy,Me2phen,x=4).经元素分析、摩尔电导和磁性的测定以及红外光谱和电子光谱等方法对这些配合物进行了表征,确定了配合物的组成和结构.初步生物活性试验表明形成异三核配合物后其杀菌活性明显提高.     

Density functional calculation of the electronic circular dichroism spectra of the transition metal complexes [M(phen)3]2+ (M = Fe, Ru, Os)

The circular dichroism spectra of the tris-bidentate metal complexes Lambda-[M(phen)3]2+, with M = Fe, Ru, Os and phen = 1,10-tris-phenanthroline, are investigated computationally, employing time-dependent density functional theory. Good agreement with experimental spectra is obtained for Ru and Os. The Lambda-[Os(phen)3]2+ spectrum is analyzed in detail. It is shown how relativistic effects red shift CD bands where the Os 5d-orbital participates to a large extent in the excitations. Further, the participation of the metal in the ligand pi --> pi exciton CD is determined to be of the order of 10%. Though solvent effects can have a noticeable effect on individual transitions and rotatory strengths, they are demonstrated to have only a very small overall effect on the resulting simulated CD spectra. For Lambda-[Fe(phen)3]2+, the results are shown to be rather sensitive to the choice of the applied hybrid and nonhybrid density functionals, and the optimized geometries based thereupon. In particular, the sign pattern of the lower-energy part (up to 33 x 10(3) cm(-1)) of the Lambda-[Fe(phen)3]2+ CD spectrum is difficult to reproduce. Some combinations of functionals and geometries yield good agreement with experiment, but no "best" approach can be devised based on the available results. Possible sources of errors in the spectrum of Lambda-[Fe(phen)3]2+ due to deficiencies in the functionals and the exchange-correlation kernels are investigated.     

Design of phenanthrimidazole-pendant cyclam and cyclen macrocyclic complex ligands as inorganic hosts: Photophysics,electrochemistry, and bimetallic complex formation

Novel ruthenium(II)bpy complexes of the phenanthrimidazole-pendant cyclen and cyclam macrocyclic ligands were synthesized as inorganic host molecules. Inorganic host design was planned as a “complex ligand” form because of its tetraaza macrocyclic unit, which has the ability to coordinate to the metals. Photophysical properties and metal selectivity of inorganic hosts RuL1A and RuL2 complex ligands were investigated by UV-vis and fluorescence spectroscopy in aqueous medium. Among Ag(I), Li(I), Na(I), K(I), Cd(II), Cr(II), Fe(II), Hg(II), Ni(II), Pb(II), Zn(II), Cu(II), Mn(III), and Co(III) metal ions, Fe(II) addition causes spectral changes for both RuL1A and RuL2 complex ligands. Electrochemical studies were performed for RuL1B and also for cis-[Ru(bpy) ₂ Cl ₂ ] . Bimetallic complexes [[Ru(bpy)₂([Ni(2-(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline])](ClO₄)₄, RuL1-NiA and [Ru(bpy)₂([Ni(2-(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline])]Cl₄, RuL1-NiB solid complexes were also obtained by the reaction of the RuL1B and Nickel(II).     

Stereoselectivity in the formation of tris-diimine complexes of Fe(II), Ru(II), and Os(II) with a C2-symmetric chiral derivative of 2,2'-bipyridine

A C2-symmetric enantiopure 4,5-bis(pinene)-2,2'-bipyridine ligand (-)-L was used to investigate the diastereoselectivity in the formation of [ML3]2+ coordination species (M = Fe(II), Ru(II), Os(II), Zn(II), Cd(II), Cu(II), Ni(II)), and [ML2Cl2] (M = Ru(II), Os(II)). The X-ray structures of the [ML3]2+ complexes were determined for Delta-[FeL3](PF6)2, Delta-[RuL3](PF6)2, Lambda-[RuL3](PF6)2, Delta-[OsL3](PF6)2, and Lambda-[OsL3](TfO)2. All of these compounds were also characterized by NMR, CD and UV/VIS absorption spectroscopy. The [FeL3]2+ diastereoisomers were studied in equilibrated solutions at various temperatures and in several solvents. The [RuL3]2+ complexes, which are thermally stable up to 200 degrees C, were photochemically equilibrated.     

Eilatin complexes of ruthenium and osmium. synthesis, electrochemical behavior, and near-IR luminescence

The synthesis and characterization of new Ru(II) and Os(II) complexes of the ligand eilatin (1) are described. The new complexes [Ru(bpy)(eil)(2)](2+) (2), [Ru(eil)(3)](2+) (3), and [Os(eil)(3)](2+) (4) (bpy = 2,2'-bipyridine; eil = eilatin) were synthesized and characterized by NMR, fast atom bombardment mass spectrometry, and elemental analysis. In the series of complexes [Ru(bpy)(x)(eil)(y)()](2+) (x + y = 3), the effect of sequential substitution of eil for bpy on the electrochemical and photophysical properties was examined. The absorption spectra of the complexes exhibit several bpy- and eil-associated pi-pi and metal-to-ligand charge-transfer (MLCT) transitions in the visible region (400-600 nm), whose energy and relative intensity depend on the number of ligands bound to the metal center (x and y). On going from [Ru(bpy)(2)(eil)](2+) (5) to 2 to 3, the d(pi)(Ru) --> pi(eil) MLCT transition undergoes a red shift from 583 to 591 to 599 nm, respectively. Electrochemical measurements performed in dimethyl sulfoxide reveal several ligand-based reduction processes, where each eil ligand can accept up to two electrons at potentials that are significantly anodically shifted (by ca. 1 V) with respect to the bpy ligands. The complexes exhibit near-IR emission (900-1100 nm) of typical (3)MLCT character, both at room temperature and at 77 K. Along the series 5, 2, and 3, upon substitution of eil for bpy, the emission maxima undergo a blue shift and the quantum yields and lifetimes increase. The radiative and nonradiative processes that contribute to deactivation of the excited level are discussed in detail.     

Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes

In search of potential anticancer drug candidates in ruthenium complexes, a series of mononuclear ruthenium complexes of the type [Ru(phen)(2)(nmit)]Cl(2) (Ru1), [Ru(bpy)(2)(nmit)]Cl(2) (Ru2), [Ru(phen)(2)(icpl)]Cl(2) (Ru3), Ru(bpy)(2)(icpl)]Cl(2) (Ru4) (phen=1,10-phenanthroline; bpy=2,2'-bipyridine; nmit=N-methyl-isatin-3-thiosemicarbazone, icpl=isatin-3-(4-Cl-phenyl)thiosemicarbazone) and [Ru(phen)(2)(aze)]Cl(2) (Ru5), [Ru(bpy)(2)(aze)]Cl(2) (Ru6) (aze=acetazolamide) and [Ru(phen)(2)(R-tsc)](ClO(4))(2) (R=methyl (Ru7), ethyl (Ru8), cyclohexyl (Ru9), 4-Cl-phenyl (10), 4-Br-phenyl (Ru11), and 4-EtO-phenyl (Ru12), tsc=thiosemicarbazone) were prepared and characterized by elemental analysis, FTIR, (1)H-NMR and FAB-MS. Effect of these complexes on the growth of a transplantable murine tumor cell line (Ehrlich Ascites Carcinoma) and their antibacterial activity were studied. In cancer study the effect of hematological profile of the tumor hosts have also been studied. In the cancer study, the complexes Ru1-Ru4, Ru10 and Ru11 have remarkably decreased the tumor volume and viable ascitic cell count as indicated by trypan blue dye exclusion test (p<0.05). Treatment with the ruthenium complexes prolonged the lifespan of Ehrlich Ascites Carcinoma (EAC) bearing mice. Tumor inhibition by the ruthenium chelates was followed by improvements in hemoglobin, RBC and WBC values. All the complexes showed antibacterial activity, except Ru5 and Ru6. Thus, the results suggest that these ruthenium complexes have significant antitumor property and antibacterial activity. The results also reflect that the drug does not adversely affect the hematological profiles as compared to that of cisplatin on the host.